(Q33933244)

30 July 2017

title

The complement system in liposome clearance: Can complement deposition be inhibited? (English)

1 reference

30 July 2017

Bradley AJ

1

1 reference

30 July 2017

Devine DV

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

Advanced Drug Delivery Reviews

30 July 2017

published in

1 reference

30 July 2017

volume

32

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

19-29

1 reference

Liposome-induced activation of the classical complement pathway does not require immunoglobulin

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Biology of serum amyloid P component

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Evidence for the binding of human serum amyloid P component to Clq and Fab gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Interaction of C-reactive protein with artificial phosphatidylcholine bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Protection of host from its own complement by membrane-bound complement inhibitors: C3 convertase inhibitors vs membrane attack complex inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Identification of proteins mediating clearance of liposomes using a liver perfusion system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Receptor versus non-receptor mediated clearance of liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Interaction of Lipopolysaccharides and Lipid A with Complement

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Fluorescence analysis of size distribution and mode of dye release from carboxyfluorescein-loaded vesicles: application to the study of complement-membrane interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Interactions of C-reactive protein and complement with liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Differing reactivities of human and guinea-pig complement on haptenized liposomes via the alternative pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Influence of vesicle size on complement-dependent immune damage to liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Liposome-complement interactions in rat serum: implications for liposome survival studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Kinetic modelling of liposome degradation in serum: effect of size and concentration of liposomes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Antibody dependent, complement mediated liver uptake of liposomes containing GM1

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Large unilamellar liposomes with low uptake into the reticuloendothelial system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Protection of retroviral vector particles in human blood through complement inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Complement inhibitory therapeutics and xenotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Sulfonated dextran inhibits complement activation and complement-dependent cytotoxicity in an in vitro model of hyperacute xenograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

Inhibition of serum complement haemolytic activity by lipid vesicles containing phosphatidylserine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900129-4

7 January 2021

10.1016/S0169-409X(97)00129-4

Identifiers

DOI

1 reference

30 July 2017

1 reference